Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Merli

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 12, 2020
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)Michele Bartoletti, Maddalena Giannella, Luigia Scudeller, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 3, 2023
Corrigendum to: "Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)" Clinical Microbiology and Infection 26 (2020) 1545-1553Michele Bartoletti, Maddalena Giannella, Luigia Scudeller, et al.
Jac-Antimicrobial Resistance|June 20, 2022
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study)Marco Falcone, Lorenzo Roberto Suardi, Giusy Tiseo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2026
Targeted peri-operative prophylaxis in patients colonized with Carbapenem Resistant Enterobacterales undergoing Liver Transplantation: a multinational cohort studyMatteo Rinaldi, Beatrice Miani, Dino Gibertoni, et al.
Infectious Diseases and Therapy|October 5, 2023
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled StudyLorenzo Piemonti, Giovanni Landoni, Antonio Voza, et al.
The Journal of Antimicrobial Chemotherapy|August 22, 2023
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscapeDaniele Roberto Giacobbe, Cristina Marelli, Greta Cattardico, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 31, 2025
Treatment and follow-up of vascular graft and endograft infection: Delphi consensus documentIlse J E Kouijzer, Marta Hernández-Meneses, Erik H J G Aarntzen, et al.
Infection Prevention in Practice|December 18, 2024
Use of ICD-9-CM coding for identifying antibiotic prescriptions during hospitalization: a Delphi consensus modelAgnese Comelli, Camilla Genovese, Giulia Renisi, et al.
Heliyon|September 9, 2024
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohortAlessandro Soria, Francesca Graziano, Giulia Ghilardi, et al.
BMC Infectious Diseases|October 16, 2025
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort studyAndrea Lombardi, Daniele Roberto Giacobbe, Davide Mangioni, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 12, 2020
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)Michele Bartoletti, Maddalena Giannella, Luigia Scudeller, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 3, 2023
Corrigendum to: "Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)" Clinical Microbiology and Infection 26 (2020) 1545-1553Michele Bartoletti, Maddalena Giannella, Luigia Scudeller, et al.
Jac-Antimicrobial Resistance|June 20, 2022
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study)Marco Falcone, Lorenzo Roberto Suardi, Giusy Tiseo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2026
Targeted peri-operative prophylaxis in patients colonized with Carbapenem Resistant Enterobacterales undergoing Liver Transplantation: a multinational cohort studyMatteo Rinaldi, Beatrice Miani, Dino Gibertoni, et al.
Infectious Diseases and Therapy|October 5, 2023
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled StudyLorenzo Piemonti, Giovanni Landoni, Antonio Voza, et al.
The Journal of Antimicrobial Chemotherapy|August 22, 2023
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscapeDaniele Roberto Giacobbe, Cristina Marelli, Greta Cattardico, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 31, 2025
Treatment and follow-up of vascular graft and endograft infection: Delphi consensus documentIlse J E Kouijzer, Marta Hernández-Meneses, Erik H J G Aarntzen, et al.
Infection Prevention in Practice|December 18, 2024
Use of ICD-9-CM coding for identifying antibiotic prescriptions during hospitalization: a Delphi consensus modelAgnese Comelli, Camilla Genovese, Giulia Renisi, et al.
Heliyon|September 9, 2024
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohortAlessandro Soria, Francesca Graziano, Giulia Ghilardi, et al.
BMC Infectious Diseases|October 16, 2025
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort studyAndrea Lombardi, Daniele Roberto Giacobbe, Davide Mangioni, et al.
Pageof 9